Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cartesian Therapeutics, Inc. (RNAC)
USD8.54
-0.08 (-0.93%)
US NASDAQ Healthcare Biotechnology
Address
7495 New Horizon Way 21703
Frederick, MD, US
Frederick, MD, US
CEO
Carsten Brunn
Website
cartesiantherapeutics.com
IPO
2016-06-22
CIK 1453687 ISIN US8162123025
Description
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD8.54
-0.08 (-0.93%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
290.3K
Beta
0.46
Float Shares
9.59M
Free Float %
36.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.39% | +2.16% | +42.64% | +33.07% | +12.53% | +18.31% | -18.30% | -75.49% | -90.52% | -97.97% | -97.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
8.54
Low
16.00
+87.4%
Consensus
16.00
+87.4%
Median
16.00
+87.4%
High
16.00
+87.4%
DCF (Unlevered)
3.78
-55.7%
DCF (Levered)
3.63
-57.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
89% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
16.00
+87.4%
|
| Last Year | 1 |
16.00
+87.4%
|
| All Time | 4 |
36.00
+321.5%
|
Quality scores
Altman Z-Score
-4.17
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-92.8% Q1'26: -92.9% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-52.6% Q1'26: -114.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-3,059.5% Q1'26: -28,412.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-3,099.9% Q1'26: -33,973.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +41.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+9.6% Q1'26: +3.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.15× Q1'26: -0.11× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 4 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.08M
est: 12.24M (-34.0%)
|
207.0K
est: 5.54M (-96.3%)
|
6.68M
est: 4.29M (+55.7%)
|
16.60M
est: 10.81M (+53.6%)
|
85.08M
est: 68.16M (+24.8%)
|
110.78M
est: 96.20M (+15.2%)
|
26.00M
est: 25.91M (+0.4%)
|
38.91M
est: 39.74M (-2.1%)
|
2.80M
est: 1.96M (+42.6%)
|
512.9K
89.2K – 1.11M
-73.9% YoY
|
368.7K
188.1K – 651.7K
-28.1% YoY
|
23.80M
12.14M – 42.08M
+6,356.3% YoY
|
90.20M
46.01M – 159.46M
+279.0% YoY
|
217.78M
111.09M – 385.01M
+141.4% YoY
|
| EBITDA |
-34.16M
est: -6.61M (-416.5%)
|
-63.37M
est: -2.99M (-2,018.8%)
|
-51.80M
est: -2.32M (-2,135.9%)
|
-65.59M
est: -5.84M (-1,023.4%)
|
-5.16M
est: -36.82M (+86.0%)
|
39.84M
est: -51.97M (+176.7%)
|
-235.03M
est: -13.99M (-1,579.5%)
|
-75.99M
est: -21.47M (-254.0%)
|
-86.71M
est: -1.06M (-8,083.5%)
|
-277.0K
-602.3K – -48.2K
+73.9% YoY
|
-199.2K
-352.1K – -101.6K
+28.1% YoY
|
-12.86M
-22.73M – -6.56M
-6,356.3% YoY
|
-48.73M
-86.14M – -24.85M
-279.0% YoY
|
-117.65M
-207.98M – -60.01M
-141.4% YoY
|
| EBIT |
-34.96M
est: -6.71M (-421.2%)
|
-64.12M
est: -3.03M (-2,013.7%)
|
-53.83M
est: -2.35M (-2,190.7%)
|
-67.32M
est: -5.92M (-1,036.8%)
|
-6.88M
est: -37.34M (+81.6%)
|
37.80M
est: -52.71M (+171.7%)
|
-235.88M
est: -14.19M (-1,561.8%)
|
-77.14M
est: -21.77M (-254.3%)
|
-86.71M
est: -1.07M (-7,968.2%)
|
-281.0K
-610.9K – -48.9K
+73.9% YoY
|
-202.0K
-357.1K – -103.0K
+28.1% YoY
|
-13.04M
-23.06M – -6.65M
-6,356.4% YoY
|
-49.42M
-87.37M – -25.21M
-279.0% YoY
|
-119.33M
-210.95M – -60.87M
-141.4% YoY
|
| Net Income |
-36.21M
est: -1.97B (+98.2%)
|
-65.32M
est: -2.03B (+96.8%)
|
-55.35M
est: -776.92M (+92.9%)
|
-68.88M
est: -451.79M (+84.8%)
|
-25.69M
est: -250.79M (+89.8%)
|
35.38M
est: 35.36M (+0.1%)
|
-219.71M
est: -1.41B (+84.5%)
|
-77.42M
est: -129.35M (+40.1%)
|
-130.30M
est: -63.35M (-105.7%)
|
-120.56M
-139.49M – -80.35M
-90.3% YoY
|
-97.45M
-129.49M – -65.41M
+19.2% YoY
|
-97.26M
-127.58M – -66.94M
+0.2% YoY
|
-70.39M
-140.65M – -25.56M
+27.6% YoY
|
-27.43M
-54.81M – -9.96M
+61.0% YoY
|
| SGA |
12.25M
est: 9.62M (+27.3%)
|
18.08M
est: 4.35M (+315.3%)
|
16.39M
est: 3.37M (+386.1%)
|
18.91M
est: 8.50M (+122.6%)
|
20.94M
est: 53.58M (-60.9%)
|
23.86M
est: 75.63M (-68.4%)
|
40.45M
est: 72.75M (-44.4%)
|
30.13M
est: 111.60M (-73.0%)
|
31.47M
est: 5.51M (+471.3%)
|
1.44M
250.5K – 3.13M
-73.9% YoY
|
1.04M
528.1K – 1.83M
-28.1% YoY
|
66.85M
34.10M – 118.17M
+6,356.3% YoY
|
253.32M
129.21M – 447.83M
+279.0% YoY
|
611.62M
311.98M – 1.08B
+141.4% YoY
|
| EPS |
-103.52
est: -83.05 (-24.7%)
|
-95.94
est: -85.72 (-11.9%)
|
-36.46
est: -32.80 (-11.2%)
|
-20.42
est: -19.07 (-7.1%)
|
-6.74
est: -10.59 (+36.3%)
|
7.33
est: 1.49 (+391.1%)
|
-49.76
est: -55.74 (+10.7%)
|
-2.99
est: -4.98 (+40.0%)
|
-5.02
est: -2.35 (-113.7%)
|
-4.00
-5.37 – -3.09
-70.1% YoY
|
-3.68
-4.99 – -2.52
+7.9% YoY
|
-3.41
-4.91 – -2.58
+7.4% YoY
|
-2.71
-5.42 – -0.98
+20.4% YoY
|
-1.06
-2.11 – -0.38
+61.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-01 | Wedbush | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-87.05M
OE per share TTM
-3.30
Owner's Yield
-38.00%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
29.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
13
Total invested
328.9K
Insider transactions (90d)
0
Beneficial owners (>5%)
2
Beneficial owners (>5%)
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
13
-57 vs prev Q
New positions
8
Closed positions
64
Increased
9
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FMR LLC | 1.37M -788.8K (-36.6%) | 9.86M -12.2M (-55.3%) | 5.26% -3.041 pp | 0.00% -0.001 pp | USD17.58 -59.0% | 7 qtrs — |
| 2 | BLACKROCK, INC. | 609.7K -39.6K (-6.1%) | 4.40M -2.2M (-33.8%) | 2.34% -0.155 pp | 0.00% +0.000 pp | USD16.69 -56.8% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 541.2K +20.5K (+3.9%) | 3.90M -1.4M (-26.7%) | 2.08% +0.077 pp | 0.00% +0.000 pp | USD19.24 -62.5% | 7 qtrs — |
| 4 | 683 CAPITAL MANAGEMENT, LLC | 280.0K +50.0K (+21.7%) | 2.02M -331.8K (-14.1%) | 1.08% +0.192 pp | 0.09% -0.035 pp | USD12.94 -44.3% | 6 qtrs — |
| 5 | ERSTE ASSET MANAGEMENT GMBH | 271.7K +11.7K (+4.5%) | 1.96M -604.8K (-23.6%) | 1.04% +0.044 pp | 0.02% -0.008 pp | USD18.47 -61.0% | 7 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 255.5K +13.7K (+5.7%) | 1.84M -629.2K (-25.5%) | 0.98% +0.052 pp | 0.00% +0.000 pp | USD19.76 -63.5% | 7 qtrs — |
| 7 | STATE STREET CORP | 199.0K +1.3K (+0.7%) | 1.43M -585.6K (-29.0%) | 0.77% +0.004 pp | 0.00% +0.000 pp | USD21.77 -66.9% | 7 qtrs — |
| 8 | MARSHALL WACE, LLP | 178.1K +93.3K (+110.1%) | 1.28M +417.7K (+48.2%) | 0.69% +0.359 pp | 0.00% +0.000 pp | USD9.33 -22.7% | 4 qtrs — |
| 9 | PRIVIUM FUND MANAGEMENT B.V. | 172.5K +172.5K (+100.0%) | 1.24M +1.2M (+100.0%) | 0.66% +0.663 pp | 0.23% +0.229 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 10 | MILLENNIUM MANAGEMENT LLC | 164.4K +139.0K (+548.2%) | 1.19M +925.9K (+357.3%) | 0.63% +0.535 pp | 0.00% +0.000 pp | USD7.67 -6.0% | 2 qtrs — |
| 11 | BANK OF AMERICA CORP /DE/ | 113.1K +99.0K (+703.8%) | 815.4K +671.6K (+467.1%) | 0.43% +0.381 pp | 0.00% +0.000 pp | USD8.14 -11.4% | 7 qtrs — |
| 12 | JACOBS LEVY EQUITY MANAGEMENT, INC | 95.8K +65.8K (+219.3%) | 690.7K +384.1K (+125.3%) | 0.37% +0.253 pp | 0.00% +0.001 pp | USD8.21 -12.2% | 3 qtrs — |
| 13 | TWO SIGMA INVESTMENTS, LP | 91.3K +91.3K (+100.0%) | 658.1K +658.1K (+100.0%) | 0.35% +0.351 pp | 0.00% +0.001 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 14 | NORTHERN TRUST CORP | 87.0K -4.3K (-4.7%) | 627.4K -305.6K (-32.8%) | 0.33% -0.017 pp | 0.00% +0.000 pp | USD18.54 -61.1% | 7 qtrs — |
| 15 | CITADEL ADVISORS LLC | 79.8K +9.3K (+13.1%) | 575.3K -145.5K (-20.2%) | 0.31% +0.035 pp | 0.00% +0.000 pp | USD15.09 -52.2% | 6 qtrs — |
| 16 | GSA CAPITAL PARTNERS LLP | 77.2K -8.9K (-10.3%) | 557.0K -323.0K (-36.7%) | 0.30% -0.034 pp | 0.05% -0.025 pp | USD10.85 -33.5% | 4 qtrs — |
| 17 | UBS GROUP AG | 67.3K +57.4K (+576.9%) | 485.5K +383.9K (+377.6%) | 0.26% +0.221 pp | 0.00% +0.000 pp | USD8.53 -15.5% | 7 qtrs — |
| 18 | WALLEYE CAPITAL LLC | 43.9K +43.9K (+100.0%) | 316.4K +316.4K (+100.0%) | 0.17% +0.169 pp | 0.00% +0.001 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 41.1K +41.1K (+100.0%) | 296.3K +296.3K (+100.0%) | 0.16% +0.158 pp | 0.00% +0.001 pp | USD7.21 +0.0% | 7 qtrs — |
| 20 | POINT72 ASSET MANAGEMENT, L.P. | 33.9K +33.9K (+100.0%) | 244.2K +244.2K (+100.0%) | 0.13% +0.130 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25.3K +405.0 (+1.6%) | 182.4K -72.0K (-28.3%) | 0.10% +0.002 pp | 0.00% +0.000 pp | USD21.41 -66.3% | 7 qtrs — |
| 22 | BANK OF NEW YORK MELLON CORP | 25.2K +1.1K (+4.3%) | 182.0K -65.2K (-26.4%) | 0.10% +0.004 pp | 0.00% +0.000 pp | USD19.71 -63.4% | 7 qtrs — |
| 23 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25.0K +— (+0.0%) | 180.3K -75.3K (-29.5%) | 0.10% 0.000 pp | 0.00% -0.002 pp | USD10.22 -29.5% | 2 qtrs — |
| 24 | TWO SIGMA ADVISERS, LP | 24.8K +24.8K (+100.0%) | 178.9K +178.9K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 25 | NUVEEN, LLC | 24.5K +— (+0.0%) | 176.6K -73.7K (-29.5%) | 0.09% 0.000 pp | 0.00% +0.000 pp | USD13.18 -45.3% | 4 qtrs — |
| 26 | MORGAN STANLEY | 23.3K +4.3K (+22.8%) | 168.0K -26.0K (-13.4%) | 0.09% +0.017 pp | 0.00% +0.000 pp | USD13.95 -48.3% | 7 qtrs — |
| 27 | IKARIAN CAPITAL, LLC | 20.8K -1.4K (-6.1%) | 150.0K -76.5K (-33.8%) | 0.08% -0.005 pp | 0.01% -0.011 pp | USD24.27 -70.3% | 7 qtrs — |
| 28 | AMERIPRISE FINANCIAL INC | 19.8K +19.8K (+100.0%) | 142.8K +142.8K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 29 | TWIN FOCUS CAPITAL PARTNERS, LLC | 19.5K +— (+0.0%) | 140.6K -58.7K (-29.5%) | 0.08% 0.000 pp | 0.02% -0.009 pp | USD18.52 -61.1% | 7 qtrs — |
| 30 | JANE STREET GROUP, LLC | 19.1K +19.1K (+100.0%) | 137.7K +137.7K (+100.0%) | 0.07% +0.074 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 31 | SQUAREPOINT OPS LLC | 18.2K +18.2K (+100.0%) | 131.3K +131.3K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 32 | BARCLAYS PLC | 17.7K +6.0K (+52.0%) | 127.3K -59.9K (-32.0%) | 0.07% +0.023 pp | 0.00% +0.000 pp | USD11.78 -38.8% | 7 qtrs — |
| 33 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17.3K +700.0 (+4.2%) | 124.7K -44.9K (-26.5%) | 0.07% +0.003 pp | 0.00% +0.000 pp | USD10.10 -28.6% | 2 qtrs — |
| 34 | JAIN GLOBAL LLC | 16.7K +16.7K (+100.0%) | 120.6K +120.6K (+100.0%) | 0.06% +0.064 pp | 0.00% +0.001 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 35 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 15.5K +15.5K (+100.0%) | 111.8K +111.8K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 36 | MILLER FINANCIAL SERVICES LLC | 13.6K +2.0K (+17.2%) | 98.4K -20.6K (-17.3%) | 0.05% +0.008 pp | 0.12% -0.022 pp | USD9.92 -27.3% | 3 qtrs — |
| 37 | ALLIANCEBERNSTEIN L.P. | 12.8K +— (+0.0%) | 92.0K -38.4K (-29.5%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD10.38 -30.5% | 3 qtrs — |
| 38 | RHUMBLINE ADVISERS | 12.1K -995.0 (-7.6%) | 87.5K -46.7K (-34.8%) | 0.05% -0.004 pp | 0.00% +0.000 pp | USD20.80 -65.3% | 7 qtrs — |
| 39 | WELLS FARGO & COMPANY/MN | 11.8K +3.9K (+49.2%) | 84.8K +4.2K (+5.2%) | 0.05% +0.015 pp | 0.00% +0.000 pp | USD13.67 -47.3% | 7 qtrs — |
| 40 | R SQUARED LTD | 10.3K +10.3K (+100.0%) | 74.3K +74.3K (+100.0%) | 0.04% +0.040 pp | 0.03% +0.035 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 41 | XTX TOPCO LTD | 10.2K +10.2K (+100.0%) | 73.8K +73.8K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.002 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 42 | DEUTSCHE BANK AG\ | 8.1K +688.0 (+9.3%) | 58.5K -17.4K (-22.9%) | 0.03% +0.003 pp | 0.00% +0.000 pp | USD17.65 -59.2% | 7 qtrs — |
| 43 | QUEST PARTNERS LLC | 6.9K +— (+0.0%) | 49.9K -20.8K (-29.5%) | 0.03% +0.000 pp | 0.00% -0.002 pp | USD12.02 -40.0% | 4 qtrs — |
| 44 | JPMORGAN CHASE & CO | 5.9K -235.0 (-3.8%) | 42.5K -20.1K (-32.2%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD24.10 -70.1% | 7 qtrs — |
| 45 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 5.1K +244.0 (+5.0%) | 36.9K -12.9K (-25.9%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD18.19 -60.4% | 7 qtrs — |
| 46 | NEW YORK STATE COMMON RETIREMENT FUND | 3.9K +— (+0.0%) | 28.1K -11.7K (-29.5%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD24.27 -70.3% | 7 qtrs — |
| 47 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 2.9K +— (+0.0%) | 21.2K -8.8K (-29.5%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD15.52 -53.5% | 5 qtrs — |
| 48 | BNP PARIBAS ARBITRAGE, SNC | 2.4K +174.0 (+7.8%) | 17.4K -5.5K (-24.0%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD14.06 -48.7% | 7 qtrs — |
| 49 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.4K +1.1K (+81.3%) | 17.2K +3.7K (+27.9%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD11.35 -36.5% | 7 qtrs — |
| 50 | ALERUS FINANCIAL NA | 1.0K +— (+0.0%) | 7.2K -3.0K (-29.5%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD10.39 -30.6% | 3 qtrs — |
| 51 | ROYAL BANK OF CANADA | 906.00 -35.3K (-97.5%) | 7.0K -363.0K (-98.1%) | 0.00% -0.136 pp | 0.00% 0.000 pp | USD11.01 -34.5% | 7 qtrs — |
| 52 | LEGAL & GENERAL GROUP PLC | 938.00 +— (+0.0%) | 6.8K -2.8K (-29.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD22.34 -67.7% | 7 qtrs — |
| 53 | RUSSELL INVESTMENTS GROUP, LTD. | 849.00 +82.0 (+10.7%) | 6.1K -1.7K (-21.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD9.94 -27.5% | 3 qtrs — |
| 54 | AMERITAS INVESTMENT PARTNERS, INC. | 708.00 +— (+0.0%) | 5.1K -2.1K (-29.5%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD24.27 -70.3% | 7 qtrs — |
| 55 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 645.00 -122.0 (-15.9%) | 4.7K -3.2K (-40.7%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD22.24 -67.6% | 7 qtrs — |
| 56 | STERLING CAPITAL MANAGEMENT LLC | 644.00 +5.0 (+0.8%) | 4.6K -1.9K (-28.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.40 -30.7% | 6 qtrs — |
| 57 | UBS ASSET MANAGEMENT AMERICAS INC | 516.00 +516.0 (+100.0%) | 3.7K +3.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 58 | AMALGAMATED BANK | 330.00 -26.0 (-7.3%) | 2.0K -2.0K (-50.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD17.23 -58.2% | 7 qtrs — |
| 59 | CITIGROUP INC | 238.00 -429.0 (-64.3%) | 1.7K -5.1K (-74.8%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD18.33 -60.7% | 7 qtrs — |
| 60 | JONES FINANCIAL COMPANIES LLLP | 200.00 +200.0 (+100.0%) | 1.4K +1.4K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD7.21 +0.0% | 1 qtrs NEW |
| 61 | CWM, LLC | 191.00 -63.0 (-24.8%) | 1.0K -2.0K (-66.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD13.05 -44.8% | 5 qtrs — |
| 62 | ADVISOR GROUP HOLDINGS, INC. | 107.00 -197.0 (-64.8%) | 770.00 -2.3K (-75.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD15.13 -52.3% | 7 qtrs — |
| 63 | OPTIVER HOLDING B.V. | 80.00 +— (+0.0%) | 577.00 -241.0 (-29.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.21 -29.4% | 2 qtrs — |
| 64 | ACTIVEST WEALTH MANAGEMENT | 66.00 +— (+0.0%) | 476.00 -199.0 (-29.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD24.26 -70.3% | 7 qtrs — |
| 65 | SBI SECURITIES CO., LTD. | 49.00 -1.0 (-2.0%) | 353.00 -158.0 (-30.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.73 -59.3% | 5 qtrs — |
| 66 | EVERSOURCE WEALTH ADVISORS, LLC | 6.00 -33.0 (-84.6%) | 43.00 -356.0 (-89.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD11.00 -34.5% | 4 qtrs — |
| 67 | PNC FINANCIAL SERVICES GROUP, INC. | 5.00 +5.0 (+100.0%) | 36.00 +36.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.20 +0.1% | 1 qtrs NEW |
| 68 | SAGEVIEW ADVISORY GROUP, LLC | 3.00 +3.0 (+100.0%) | 22.00 +22.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.00 +3.0% | 1 qtrs NEW |
| 69 | PARALLEL ADVISORS, LLC | 103.00 +— (+0.0%) | 22.00 -9.0 (-29.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD10.57 -31.8% | 8 qtrs — |
| 70 | SRS CAPITAL ADVISORS, INC. | — -111.0 (-100.0%) | — -1.1K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 71 | BIOIMPACT CAPITAL LLC | — -380.0K (-100.0%) | — -3.9M (-100.0%) | 0.00% -1.463 pp | 0.00% -0.636 pp | USD— | 7 qtrs SOLD |
| 72 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | — -439.0 (-100.0%) | — -4.5K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 73 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | — -4.6K (-100.0%) | — -46.6K (-100.0%) | 0.00% -0.018 pp | 0.00% -0.004 pp | USD— | 5 qtrs SOLD |
| 74 | SPIRE WEALTH MANAGEMENT | — -50.0 (-100.0%) | — -511.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 75 | NISA INVESTMENT ADVISORS, LLC | — -107.0 (-100.0%) | — -1.1K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
| 76 | FREESTONE CAPITAL HOLDINGS, LLC | — -25.9K (-100.0%) | — -264.9K (-100.0%) | 0.00% -0.100 pp | 0.00% -0.008 pp | USD— | 7 qtrs SOLD |
| 77 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | — -1.0K (-100.0%) | — -10.3K (-100.0%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
| 78 | GAMMA INVESTING LLC | — -15.0 (-100.0%) | — -153.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 79 | VIRTUS INVESTMENT ADVISERS, INC. | — -11.1K (-100.0%) | — -113.6K (-100.0%) | 0.00% -0.043 pp | 0.00% -0.033 pp | USD— | 4 qtrs SOLD |
| 80 | SIREN, L.L.C. | — -563.3K (-100.0%) | — -5.8M (-100.0%) | 0.00% -2.168 pp | 0.00% -0.225 pp | USD— | 6 qtrs SOLD |
| 81 | GF FUND MANAGEMENT CO. LTD. | — -549.0 (-100.0%) | — -5.6K (-100.0%) | 0.00% -0.002 pp | 0.00% 0.000 pp | USD— | 5 qtrs SOLD |
| 82 | LARSON FINANCIAL GROUP LLC | — -3.0 (-100.0%) | — -31.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 83 | DAIWA SECURITIES GROUP INC. | — -84.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 42 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.63% | 137.6K | 0.20% |
| 2 | Janus Henderson Small Cap Growth Alpha ETF JSML | 0.49% | 1.81M | 0.30% |
| 3 | iShares Micro-Cap ETF IWC | 0.03% | 417.4K | 0.60% |
| 4 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.01% | 352.8K | 0.30% |
| 5 | iShares Russell 2000 Value ETF IWN | 0.01% | 887.3K | 0.24% |
| 6 | Vanguard Russell 2000 Value ETF VTWV | 0.00% | 52.0K | 0.06% |
| 7 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 114.9K | 0.30% |
| 8 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 2.2K | 0.39% |
| 9 | Global X - Russell 2000 ETF RSSL | 0.00% | 58.1K | 0.08% |
| 10 | iShares Russell 2000 ETF IWM | 0.00% | 3.27M | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
6.00
Bullish
Ratio by volume
3.00
Bullish
Buys
24
Sells
4
Shares acquired
1.00M
Shares disposed
44.5K
Cash buys
—
Cash sales
3.00
Net activity
+957,715
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Kalayoglu Murat | 10% Owner | M-Exempt | A | Common Stock | 758,001 | 0.00 | — | 5,313,261 | I | ↗ |
| 2026-04-02 | Hoge Elizabeth | 10% Owner | M-Exempt | A | Common Stock | 758,001 | 0.00 | — | 5,313,261 | I | ↗ |
| 2026-03-13 | Singer Michael | Director | G-Gift | D | Common Stock | 6,555 | 0.00 | — | 49,578 | D | ↗ |
| 2026-01-06 | Miljkovic Milos | Officer | S-Sale | D | Common Stock | 3,573 | 6.82 | 24.4K | 58,820 | D | ↗ |
| 2026-01-06 | Davis Blaine | Officer | S-Sale | D | Common Stock | 10,591 | 6.82 | 72.2K | 121,220 | D | ↗ |
| 2026-01-06 | Brunn Carsten | Director / Officer | S-Sale | D | Common Stock | 23,766 | 6.82 | 162.1K | 323,530 | D | ↗ |
| 2026-01-02 | ZENNER PATRICK J | Director | A-Award | A | Stock Option (Right to Buy) | 7,800 | 6.76 | 52.7K | 7,800 | D | ↗ |
| 2026-01-02 | Singer Michael | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 56,133 | D | ↗ |
| 2026-01-02 | Seymour June Ann | Officer | A-Award | A | Common Stock | 6,500 | 0.00 | — | 6,500 | D | ↗ |
| 2026-01-02 | SPRINGER TIMOTHY A | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 7,800 | 6.76 | 52.7K | 7,800 | D | ↗ |
| 2026-01-02 | Miljkovic Milos | Officer | A-Award | A | Employee Stock Option (right to buy) | 77,000 | 6.76 | 520.5K | 77,000 | D | ↗ |
| 2026-01-02 | Malik Kemal | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 11,133 | D | ↗ |
| 2026-01-02 | Kalayoglu Murat | Director / 10% Owner | A-Award | A | Common Stock | 2,600 | 0.00 | — | 511,577 | D | ↗ |
| 2026-01-02 | English Emily | Officer | A-Award | A | Employee Stock Option (right to buy) | 71,000 | 6.76 | 480.0K | 71,000 | D | ↗ |
| 2026-01-02 | DeSilva Nishan M | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 11,366 | D | ↗ |
| 2026-01-02 | Davis Blaine | Officer | A-Award | A | Employee Stock Option (right to buy) | 109,000 | 6.76 | 736.8K | 109,000 | D | ↗ |
| 2026-01-02 | Brunn Carsten | Director / Officer | A-Award | A | Common Stock | 143,200 | 0.00 | — | 347,296 | D | ↗ |
| 2026-01-02 | BARABE TIMOTHY C | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 56,966 | D | ↗ |
| 2025-12-30 | English Emily | Officer | M-Exempt | A | Common Stock | 7,500 | 3.30 | 24.8K | 70,226 | D | ↗ |
| 2025-12-16 | Bot Adrian Ion | Director | A-Award | A | Stock Option (Right to Buy) | 17,200 | 8.29 | 142.6K | 17,200 | D | ↗ |
| 2025-12-04 | BARABE TIMOTHY C | Director | P-Purchase | A | Common Stock | 30,000 | 6.86 | 205.8K | 54,366 | D | ↗ |
| 2025-11-28 | English Emily | Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,500 | 3.30 | 24.8K | 26,869 | D | ↗ |
| 2025-11-18 | Singer Michael | Director | G-Gift | D | Common Stock | 20,000 | 0.00 | — | 53,533 | D | ↗ |
| 2025-10-27 | Seymour June Ann | Officer | A-Award | A | Employee Stock Option (right to buy) | 50,000 | 8.85 | 442.5K | 50,000 | D | ↗ |
| 2025-05-12 | English Emily | Officer | M-Exempt | A | Common Stock | 7,500 | 3.30 | 24.8K | 55,226 | D | ↗ |
| 2025-04-15 | English Emily | Officer | M-Exempt | A | Common Stock | 7,500 | 3.30 | 24.8K | 47,726 | D | ↗ |
| 2025-04-11 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 6,412 | 10.77 | 69.1K | 8,643,685 | D | ↗ |
| 2025-04-10 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 609 | 10.92 | 6.7K | 8,637,273 | D | ↗ |
| 2025-04-09 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 178 | 9.95 | 1.8K | 571,580 | I | ↗ |
| 2025-03-20 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 54,889 | 15.59 | 855.6K | 8,621,325 | D | ↗ |
| 2025-03-19 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 20,234 | 14.97 | 303.0K | 8,566,436 | D | ↗ |
| 2025-03-18 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 14,740 | 14.42 | 212.6K | 8,546,202 | D | ↗ |
| 2025-01-14 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 4,022 | 18.00 | 72.4K | 8,531,462 | D | ↗ |
| 2025-01-13 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 8,983 | 17.78 | 159.7K | 8,527,440 | D | ↗ |
| 2025-01-10 | Jewell Christopher M | Officer | M-Exempt | D | Stock Option (Right to Buy) | 9,000 | 3.23 | 29.1K | 67,432 | D | ↗ |
| 2025-01-06 | Miljkovic Milos | Officer | S-Sale | D | Common Stock | 948 | 16.83 | 16.0K | 35,393 | D | ↗ |
| 2025-01-06 | Kurtoglu Metin | Officer | S-Sale | D | Common Stock | 2,458 | 16.83 | 41.4K | 62,258 | D | ↗ |
| 2025-01-06 | Jewell Christopher M | Officer | S-Sale | D | Common Stock | 1,286 | 16.83 | 21.6K | 53,490 | D | ↗ |
| 2025-01-06 | English Emily | Officer | S-Sale | D | Common Stock | 906 | 16.83 | 15.2K | 40,226 | D | ↗ |
| 2025-01-06 | Davis Blaine | Officer | S-Sale | D | Common Stock | 4,028 | 16.83 | 67.8K | 94,811 | D | ↗ |
| 2025-01-06 | Brunn Carsten | Director / Officer | S-Sale | D | Common Stock | 8,708 | 16.83 | 146.6K | 204,096 | D | ↗ |
| 2025-01-03 | Miljkovic Milos | Officer | S-Sale | D | Common Stock | 932 | 16.72 | 15.6K | 36,341 | D | ↗ |
| 2025-01-03 | Kurtoglu Metin | Officer | S-Sale | D | Common Stock | 2,417 | 16.72 | 40.4K | 64,716 | D | ↗ |
| 2025-01-03 | Jewell Christopher M | Officer | S-Sale | D | Common Stock | 1,264 | 16.72 | 21.1K | 54,776 | D | ↗ |
| 2025-01-03 | English Emily | Officer | S-Sale | D | Common Stock | 891 | 16.72 | 14.9K | 41,132 | D | ↗ |
| 2025-01-03 | Davis Blaine | Officer | S-Sale | D | Common Stock | 3,961 | 16.72 | 66.2K | 98,839 | D | ↗ |
| 2025-01-03 | Brunn Carsten | Director / Officer | S-Sale | D | Common Stock | 8,563 | 16.72 | 143.2K | 212,804 | D | ↗ |
| 2025-01-02 | ZENNER PATRICK J | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 10,374 | D | ↗ |
| 2025-01-02 | Singer Michael | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 73,533 | D | ↗ |
| 2025-01-02 | SPRINGER TIMOTHY A | Director / 10% Owner | A-Award | A | Common Stock | 2,600 | 0.00 | — | 8,510,495 | D | ↗ |
| 2025-01-02 | Miljkovic Milos | Officer | A-Award | A | Common Stock | 19,000 | 0.00 | — | 37,273 | D | ↗ |
| 2025-01-02 | Malik Kemal | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 8,533 | D | ↗ |
| 2025-01-02 | Kurtoglu Metin | Officer | A-Award | A | Employee Stock Option (right to buy) | 47,400 | 16.93 | 802.5K | 47,400 | D | ↗ |
| 2025-01-02 | Kalayoglu Murat | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 7,800 | 16.93 | 132.1K | 7,800 | D | ↗ |
| 2025-01-02 | Jewell Christopher M | Officer | A-Award | A | Employee Stock Option (right to buy) | 47,400 | 16.93 | 802.5K | 47,400 | D | ↗ |
| 2025-01-02 | English Emily | Officer | A-Award | A | Common Stock | 16,100 | 0.00 | — | 42,023 | D | ↗ |
| 2025-01-02 | DeSilva Nishan M | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 8,766 | D | ↗ |
| 2025-01-02 | Davis Blaine | Officer | A-Award | A | Common Stock | 22,000 | 0.00 | — | 102,800 | D | ↗ |
| 2025-01-02 | COX CARRIE SMITH | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 15,629 | D | ↗ |
| 2025-01-02 | Brunn Carsten | Director / Officer | A-Award | A | Common Stock | 57,500 | 0.00 | — | 221,367 | D | ↗ |
| 2025-01-02 | BARABE TIMOTHY C | Director | A-Award | A | Common Stock | 2,600 | 0.00 | — | 24,366 | D | ↗ |
| 2024-12-26 | Singer Michael | Director | G-Gift | D | Common Stock | 20,000 | 0.00 | — | 70,933 | D | ↗ |
| 2024-12-26 | English Emily | Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,650 | 3.30 | 25.2K | 49,369 | D | ↗ |
| 2024-12-23 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 5,181 | 19.00 | 98.4K | 8,507,895 | D | ↗ |
| 2024-12-20 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 21,800 | 18.94 | 413.0K | 8,502,714 | D | ↗ |
| 2024-12-19 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 3,376 | 18.93 | 63.9K | 8,480,914 | D | ↗ |
| 2024-12-10 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,901 | 1.41 | 4.1K | 79,099 | D | ↗ |
| 2024-12-09 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,763 | 1.41 | 15.2K | 82,000 | D | ↗ |
| 2024-11-21 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 32,789 | 1.41 | 46.2K | 92,763 | D | ↗ |
| 2024-11-20 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,700 | 1.41 | 8.0K | 125,552 | D | ↗ |
| 2024-11-20 | Jewell Christopher M | Officer | M-Exempt | D | Stock Option (Right to Buy) | 14,000 | 3.23 | 45.2K | 76,432 | D | ↗ |
| 2024-11-19 | Singer Michael | Director | G-Gift | D | Common Stock | 28,821 | 0.00 | — | 90,933 | D | ↗ |
| 2024-11-19 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 200 | 1.41 | 282.00 | 131,252 | D | ↗ |
| 2024-11-18 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 38,114 | 17.96 | 684.4K | 8,435,525 | D | ↗ |
| 2024-11-18 | Kurtoglu Metin | Officer | M-Exempt | D | Stock Option (Right to Buy) | 34,400 | 1.41 | 48.5K | 131,452 | D | ↗ |
| 2024-11-15 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 277,246 | 17.09 | 4.74M | 8,397,411 | D | ↗ |
| 2024-11-15 | Miljkovic Milos | Officer | M-Exempt | A | Common Stock | 20,000 | 3.23 | 64.6K | 38,273 | D | ↗ |
| 2024-11-15 | Kurtoglu Metin | Officer | S-Sale | D | Common Stock | 22,068 | 17.20 | 379.5K | 51,033 | D | ↗ |
| 2024-11-15 | Jewell Christopher M | Officer | M-Exempt | D | Stock Option (Right to Buy) | 16,065 | 3.23 | 51.9K | 90,432 | D | ↗ |
| 2024-11-14 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 74,157 | 16.19 | 1.20M | 8,097,923 | D | ↗ |
| 2024-11-14 | Miljkovic Milos | Officer | S-Sale | D | Common Stock | 35,000 | 16.13 | 564.6K | 18,273 | D | ↗ |
| 2024-11-14 | Kurtoglu Metin | Officer | S-Sale | D | Common Stock | 21,900 | 16.33 | 357.6K | 55,033 | D | ↗ |
| 2024-11-14 | Jewell Christopher M | Officer | S-Sale | D | Common Stock | 18,550 | 16.34 | 303.1K | 43,440 | D | ↗ |
| 2024-10-11 | Kalayoglu Murat | Director / 10% Owner | M-Exempt | A | Common Stock | 1,518,373 | 0.00 | — | 4,555,260 | I | ↗ |
| 2024-10-11 | Hoge Elizabeth | 10% Owner | M-Exempt | A | Common Stock | 1,518,373 | 0.00 | — | 4,555,260 | I | ↗ |
| 2024-10-04 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 4,879 | 23.93 | 116.8K | 8,023,766 | D | ↗ |
| 2024-10-03 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 10,249 | 19.01 | 194.9K | 7,863,655 | D | ↗ |
| 2024-10-02 | SPRINGER TIMOTHY A | Director / 10% Owner | J-Other | A | Warrant (Right to Buy) | 20,045 | 46.50 | 932.1K | 20,045 | I | ↗ |
| 2024-09-25 | SPRINGER TIMOTHY A | Director / 10% Owner | M-Exempt | A | Common Stock | 1,636,832 | 0.00 | — | 6,016,731 | D | ↗ |
| 2024-08-12 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 8,016 | 12.72 | 102.0K | 11,509 | — | ↗ |
| 2024-08-12 | BARABE TIMOTHY C | Director | P-Purchase | A | Common Stock | 7,500 | 12.70 | 95.3K | 21,766 | — | ↗ |
| 2024-07-02 | SPRINGER TIMOTHY A | Director / 10% Owner | A-Award | A | Series B Non-Voting Convertible Preferred Stock | 1,636,832 | 20.00 | 32.74M | 1,636,832 | — | ↗ |
| 2024-07-01 | Malik Kemal | Director | A-Award | A | Common Stock | 5,933 | 0.00 | — | 5,933 | — | ↗ |
| 2024-04-09 | English Emily | Officer | — | D | Common Stock | 0 | 0.00 | — | 18,273 | — | ↗ |
| 2024-04-08 | Singer Michael | Director | M-Exempt | A | Common Stock | 7,005 | 0.00 | — | 7,127 | — | ↗ |
| 2024-04-08 | SPRINGER TIMOTHY A | Director / 10% Owner | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 24,785 | 0.00 | — | 0 | — | ↗ |
| 2024-04-08 | Miljkovic Milos | Officer | M-Exempt | A | Stock Option (Right to Buy) | 85,528 | 3.23 | 276.3K | 85,528 | — | ↗ |
| 2024-04-08 | Kurtoglu Metin | Officer | M-Exempt | A | Stock Option (Right to Buy) | 213,820 | 1.41 | 301.5K | 213,820 | — | ↗ |
| 2024-04-08 | Kalayoglu Murat | Director / 10% Owner | M-Exempt | D | Series A Non-Voting Convertible Preferred Stock | 14,756 | 0.00 | — | 0 | — | ↗ |
| 2024-04-08 | Jewell Christopher M | Officer | M-Exempt | D | Stock Option (Right to Buy) | 4,276 | 107.59 | 460.1K | 0 | — | ↗ |
| 2024-04-08 | Hoge Elizabeth | 10% Owner | C-Conversion | D | Series A Non-Voting Convertible Preferred Stock | 14,756 | 0.00 | — | 0 | — | ↗ |
| 2024-03-26 | SPRINGER TIMOTHY A | Director / 10% Owner | M-Exempt | A | Common Stock | 1,970,443 | 1.46 | 2.88M | 33,043,849 | — | ↗ |
| 2024-03-18 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 800 | 0.61 | 488.00 | 104,818 | — | ↗ |
| 2024-03-15 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 537,500 | 0.59 | 314.5K | 31,054,362 | — | ↗ |
| 2024-03-14 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 2,000 | 0.53 | 1.1K | 102,818 | — | ↗ |
| 2024-03-13 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 3,200 | 0.58 | 1.9K | 100,818 | — | ↗ |
| 2024-03-12 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 1,200 | 0.61 | 734.64 | 97,618 | — | ↗ |
| 2024-03-11 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 1,200 | 0.65 | 784.92 | 96,418 | — | ↗ |
| 2024-03-08 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 4,800 | 0.66 | 3.2K | 95,218 | — | ↗ |
| 2024-02-07 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 2,400 | 0.66 | 1.6K | 90,418 | — | ↗ |
| 2024-02-06 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 800 | 0.65 | 520.00 | 88,018 | — | ↗ |
| 2024-01-17 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 800 | 0.69 | 552.00 | 87,218 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.6K
Shares Outstanding
26.51M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Carsten Brunn, Ph.D. President and Chief Executive Officer | 674.0K | — | 973.5K | 2.31M | 364.0K | 4.1K | 4.33M | 75.93% | ↗ |
| 2 | 2025 | Metin Kurtoglu, M.D., Ph.D. Former Chief Technology Officer | 163.5K | — | 775.9K | 984.4K | 60.4K | 489.7K | 2.47M | 71.15% | ↗ |
| 3 | 2025 | Christopher Jewell, Ph.D. Former Chief Scientific Officer | 390.7K | — | 375.0K | 661.8K | 144.2K | 444.0K | 2.02M | 51.44% | ↗ |
| 4 | 2025 | Blaine Davis Chief Financial Officer | 475.9K | — | 372.5K | 884.1K | 205.6K | 11.9K | 1.95M | 64.44% | ↗ |
| 5 | 2025 | Milos Miljkovic, M.D. Chief Medical Officer | 439.0K | — | 321.7K | 766.4K | 118.5K | 11.9K | 1.66M | 65.65% | ↗ |
| 6 | 2024 | Carsten Brunn, Ph.D. President and Chief Executive Officer | 642.7K | — | 3.07M | 3.14M | 459.5K | 2.2K | 7.31M | 84.90% | ↗ |
| 7 | 2024 | Blaine Davis Chief Financial Officer | 462.0K | — | 1.60M | 1.63M | 240.2K | 34.9K | 3.97M | 81.44% | ↗ |
| 8 | 2024 | Metin Kurtoglu, M.D., Ph.D. Former Chief Technology Officer | 431.5K | — | 1.01M | 1.03M | 228.8K | 9.6K | 2.71M | 75.31% | ↗ |
| 9 | 2024 | Christopher Jewell, Ph.D. Former Chief Scientific Officer | 411.9K | — | 513.6K | 524.5K | 218.4K | 19.3K | 1.69M | 61.51% | ↗ |
| 10 | 2024 | Milos Miljkovic, M.D. Chief Medical Officer | 392.3K | — | 361.8K | 369.5K | 208.0K | 17.4K | 1.35M | 54.21% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carsten Brunn | President, Chief Executive Officer & Chairman of the Board | 1M | — |
| Metin Kurtoglu | Consultant | 713.7K | — |
| Blaine T. Davis | Chief Financial Officer | 693.3K | male |
| Emily English | Chief Operating Officer | 589.8K | — |
| Milos Miljkovic | Chief Medical Officer | 569.4K | — |
| June Seymour | Chief Accounting Officer | — | female |
| Matthew Bartholomae | General Counsel & Secretary | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RNAC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
